The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2019 | Assessing the role of CAR-T in CLL
David Maloney, MD, PhD, Fred Hutchinson Cancer Center, Seattle, and Johannes Schetelig, MD, WA, University of Dresden, Dresden, Germany, speaking at a roundtable discussion at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK. The speakers elaborate on the future of CAR-T and cellular therapy in chronic lymphocytic leukemia (CLL), particularly as an alternative to allogeneic stem cell transplantation.
